÷°¡Á¦ | ÀÀ°íÃËÁøÁ¦, gel |
---|---|
ÇØ´ç°Ë»ç | ÀϹÝÈÇÐ °Ë»ç, ¸é¿ªÇ÷û °Ë»ç µî |
°Ëü·® | 5mL |
º¸°ü | ¿ë±â: ½Ç¿Â, Ç÷û ºÐ¸® ÈÄ °Ë»çÇ׸ñ¿¡ µû¶ó ³Ãµ¿, ³ÃÀå, ½Ç¿Â |
Âü°í»çÇ× | ¾à 30ºÐ°£ ½Ç¿Â¿¡¼ ¹æÄ¡ÇÏ¿© ÀÀ°í½ÃŲ ÈÄ Ã¤Ç÷ ÈÄ 2½Ã°£ À̳» ¿ø½ÉºÐ¸® |
ÃֽŠ°Ë»çÇ׸ñ°ú °Ë»çÆгÎÀ» È®ÀÎÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
°ËüÁ¾·ù |
SST (Serum separating tube) |
|
---|---|---|
°Ëü·® | 1mL | |
°Ëüº¸°ü | ³ÃÀå | |
°Ëü¾ÈÁ¤¼º | ³ÃÀå: 1ÀÏ ³Ãµ¿: 5°³¿ù |
|
Âü°íÄ¡ | [ phi (Prostate Health Index) ] PSA : ¡Â4.00 free PSA : Not established p2PSA : Not established % free PSA : > 25.00% ÀÏ ¶§, Àü¸³¼±¾ÏÀÇ À§Çèµµ°¡ ³·½À´Ï´Ù. |
|
ÀÓ»óÀûÀÇÀÇ | Àü¸³¼±¾Ï ÀǽÉȯÀÚ¸¦ ´ë»óÀ¸·Î Àü¸³¼±¾ÏÀ» ¼±º°Çϱâ À§ÇÑ °Ë»ç * PSA, free PSA, p2PSA °¢°¢ÀÇ Á¤·® °ªÀ» ±¸ÇÑ ÈÄ phi¸¦ »êÃâ * Âü°íÄ¡ phi Range Probability of Cancer 95% Confidence Interval 0-26.9 9.8% 5.2-15.4% 27.0-35.9 16.8% 11.3-22.2% 36.0-54.9 33.3% 26.8-39.9% ¡Ã55.0 50.1% 39.8-61.0% |
|
ÁÖÀÇ»çÇ× |
ÀÌ °Ë»ç´Â Beckman Coulter »çÀÇ ½Ã¾à°ú Àåºñ¸¦ ÀÌ¿ëÇÑ °Ë»ç·Î ´Ù¸¥ Á¦Á¶»çÀÇ °á°ú¿Í È¥¿ëµÇÁö ¾Ê½À´Ï´Ù. ´Ù¸¥ Á¦Á¶»çÀÇ ½Ã¾àÀ¸·Î ÃßÀû °Ë»ç ½Ã °á°ú Çؼ®¿¡ ÁÖÀÇ°¡ ÇÊ¿äÇÕ´Ï´Ù. |
|
Çʼö¼·ù | ||
ÃֽŰø¹® | ||
±Þ¿©±âÁØ | Prostate Health IndexÀÇ ¼ö°¡ »êÁ¤¹æ¹ý [°í½Ã Á¦2021-183È£] Àü¸³¼±Æ¯ÀÌÇ׿ø °Ë»ç°á°ú Àü¸³¼±¾ÏÀÌ ÀǽɵǴ ȯÀÚ¿¡¼ Àü¸³¼±¾Ï ¼±º°À» À§ÇÑ Ãß°¡ Áø´ÜÀ» À§ÇØ ½Ç½ÃÇÏ´Â Prostate Health Index(PHI)´Â p2PSA, Àü¸³¼±Æ¯ÀÌÇ׿ø(PSA), À¯¸® Àü¸³¼±Æ¯ÀÌÇ׿ø(Free PSA) °¢°¢ÀÇ Á¤·® °ªÀ» ±¸ÇÑ ÈÄ °è»ê¿¡ ÀÇÇØ »êÃâµÇ¹Ç·Î ¡¸°Ç°º¸Çè ÇàÀ§ ±Þ¿©.ºñ±Þ¿© ¸ñ·ÏÇ¥ ¹× ±Þ¿© »ó´ë°¡Ä¡Á¡¼ö¡¹ÀÇ ÇØ´ç ºÐ·ùÇ׸ñ¸¸ °¢°¢ »êÁ¤ÇÔ. (2021.7.1. ½ÃÇà) |